Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: Research: Compendia: Research Models: APP Mutations
APPArcSwe

Updated 30 March 2010

General Information

Transgene: Human APP cDNA clone (3'-UTR extended to SmaI at +3100) with the Arctic mutation (E693G) and with the Swedish mutation (KM670/671NL) was generated, attached to a modified Kozak sequence, inserted into the murine Thy-1 promoter and sequenced. The construct was linearized with NotI and purified with β-agarase, microinjected (2 μg/ml) into pronuclear oocytes of C57BL/6-CBA-F1 mice and implanted into pseudopregnant foster mothers at the two-cell stage.

Mutation: Arctic mutation (E693G) and Swedish mutation (KM670/671NL)

Promoter: Murine Thy-1 promoter

Mouse Strain: C57BL/6J-CBA-F1; C57BL/6J-CBA; C57Bl/6J; C57Bl/6J, (backcrossed for five generations)

Phenotype

Neuropathological Analysis:

Strong intraneuronal Aβ aggregation which is associated with an early onset of extracellular amyloid deposition at around 5-6 months of age. Cerebrovascular amyloid angiopathy (CAA) is present, mainly in the thalamus and cerebral cortex, but congophilic parenchymal plaque depositon is the dominating neuropathological feature. Dissolution of Aβ deposits requires formic acid, like in postmortem Alzheimer's disease brain.

The inclusion of the Artic mutation in the transgene results in enhanced accumulation of soluble Aβ aggregates, such as Aβ protofibrils, facilitated accumulation of Aβ inside neurons and more robust senile plaques.

Behavioral Phenotype:

Spatial learning deficits at 4-8 months of age in Morris water maze.

Availability

Non-commercial use:
Lars Nilsson, lars.nilsson@pubcare.uu.se
Department of Public Health and Caring Sciences
Rudbeck Laboratory, Molecular Geriatrics
Uppsala University, Sweden

Reference

Primary:

Lord A, Kalimo H, Eckman C, Zhang X-O, Lannfelt L, Nilsson LNG. The Arctic Alzheimer mutation facilitates early intraneuronal Abeta aggregation and senile plaque formation in transgenic mice. Neurobiol. Aging. 2006; 27(1):67-77. Abstract

Associated:

Sahlin C, Lord A, Magnusson K, Englund H, Almeida CG, Greengard P, Nyberg F, Gouras GK, Lannfelt L, Nilsson LN. The Arctic Alzheimer mutation favors intracellular amyloid-beta production by making amyloid precursor protein less available to alpha-secretase. J Neurochem. 2007 May 1;101(3):854-62. Abstract

Englund H, Sehlin D, Johansson AS, Nilsson LN, Gellerfors P, Paulie S, Lannfelt L, Pettersson FE. Sensitive ELISA detection of amyloid-beta protofibrils in biological samples. J Neurochem. 2007 Oct 1;103(1):334-45. Abstract

Philipson O, Hammarström P, Nilsson KP, Portelius E, Olofsson T, Ingelsson M, Hyman BT, Blennow K, Lannfelt L, Kalimo H, Nilsson LN. A highly insoluble state of Abeta similar to that of Alzheimer's disease brain is found in Arctic APP transgenic mice. Neurobiol Aging. 2008 Jan 11; Abstract

Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark

See recent updates
Alzheimer's Disease Mouse Model Resource
Considerations for Choosing Controls
Research Tools

Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad